rxstat › Shortages › Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria

Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria (Boostrix) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria products are in shortage in Canada (1 of 1 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 31, 2026.

A vaccine used to help protect against diphtheria, tetanus, and whooping cough.

Products affected
1 / 1
In shortage since
May 29, 2026
Est. full return
Aug 31, 2026
Reports on file
3
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
BOOSTRIX
2.5MCG 20UNIT 8MCG 8MCG 2UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02247600 · since May 29, 2026, est. end Aug 31, 2026 · Disruption of the manufacture of the drug.
Resolved
BOOSTRIX
2.5MCG 8MCG 8MCG 20UNIT 2UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02247600 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
Resolved
BOOSTRIX
2.5MCG 8MCG 8MCG 20UNIT 2UNIT · SUSPENSION · GLAXOSMITHKLINE INC
DIN 02247600 · ended May 15, 2023 · Delay in shipping of the drug.

What's happening

Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria is currently affected by an active shortage report filed with Health Canada by GLAXOSMITHKLINE INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria is classified under “BACTERIAL VACCINES” (ATC J07AX).

Recent changes

Common questions

What is Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria used for?

A vaccine used to help protect against diphtheria, tetanus, and whooping cough.

When will Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria be back in stock in Canada?

The latest manufacturer estimate is Aug 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussis Diphtheria in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (bacterial vaccines)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Menveo (Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Gr…) No current shortage Capvaxive (Corynebacterium Diphtheriae Crm-197 Protein Pneumococcal Pol…) No current shortage Vaxneuvance (Pneumococcal Polysaccharide Serotype 7f 19f 3 5 Corynebacter…) No current shortage Adacel (Tetanus Toxoid Fimbriae Types 2 / 3 Pertactin Filamentous Ha…) No current shortage Prevnar (Corynebacterium Diphtheriae Crm-197 Protein Pneumococcal Pol…) Discontinued 0 of 1 reported products affected Hiberix (Haemophilus Influenzae Type B-prp / Tetanus Toxoid Conjugate) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.